Nā ʻano hana
Ka palena ʻike: PG I≤2.0 ng/mL , PG II≤ 1.0 ng/mL;
Laulā laina:
PG I: 2.0-200.0 ng/mL, PG II: 1.0-100.0 ng/mL;
Koefficient huikau laina R ≥ 0.990;
Ka pololei: i loko o ka puʻupuʻu CV ʻo ≤ 15%;ma waena o nā pūʻulu CV he ≤ 20%;
Pono: ʻaʻole e oi aku ka haʻihaʻi pili o nā hopena ana i ka ±15% ke hoʻāʻo ʻia ka calibrator pololei.
1. E mālama i ka mea ʻike maka ma 2~30 ℃.Kūpaʻa ka buffer a hiki i 18 mahina.
2. E kūʻai i ka cassette hōʻike Aehealth Ferritin Rapid Quantitative ma 2~30 ℃, a hiki i ka 18 mahina.
3. Pono e hoʻohana i ka pahu hoʻāʻo i loko o 1 hola ma hope o ka wehe ʻana i ka ʻeke.
ʻO ka Pepsinogen kahi protease precursor i hūnā ʻia e ka ʻōpū o ka ʻōpū a hiki ke hoʻokaʻawale ʻia i ʻelua mau ʻano: PG I a me PG II.Ua huna ʻia ʻo PG I e nā keʻena nui o nā kelepa kālā a me nā pūnaewele mucus cervical, a ua hūnā ʻia ʻo PG II e nā kelepa fundus, nā ʻili pyloric, a me nā kelepa Brunner.ʻO ka hapa nui o ka PG synthesized e komo i loko o ka ʻōpū o ka ʻōpū a hoʻāla ʻia i ka pepsin ma lalo o ka hana o ka waikawa gastric.ʻO ka maʻamau, hiki i ka 1% o ka PG ke komo i ke kahe koko ma o ka ʻōpū o ka ʻōpū, a ʻo ka neʻe ʻana o ka PG i loko o ke koko e hōʻike ana i kona pae huna.ʻO PG I kahi hōʻailona o ka hana o nā ʻōpū oxyntic gland cell.ʻO ka hoʻonui ʻia ʻana o ka ʻakika ʻōpū e hoʻonui i ka PG I, e hoʻemi ana i ka huna a i ʻole e hōʻemi i ka atrophy o ka ʻōpū mucosal gland;ʻOi aku ka pilina o PG II me nā ʻeha o ka ʻōpū o ka ʻōpū (hoʻohālikelike ʻia me ka mucosa antral gastric).ʻO ke kiʻekiʻe e pili ana i ka fundus gland atrophy, gastric epithelial metaplasia a i ʻole pseudopyloric gland metaplasia, a me dysplasia;i ke kaʻina o ka fundus gland mucosal atrophy, e emi ana ka nui o nā keena kumu huna i ka PG I a me ka piʻi ʻana o ka nui o nā pūnaewele pyloric gland, e hopena i ka PG I Ua emi ka / PG II ratio.No laila, hiki ke hoʻohana ʻia ka lakio PG I/PG II ma ke ʻano he hōʻailona o ka atrophy mucosal gland gastric fundic.